Clinical Trials for Cullinan Therapeutics

Explore 9 clinical trials worldwide

Showing 1-9 of 9 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Cullinan Therapeutics

Clinical Trials (9)

NCT07041099
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
PHASE1Recruiting
36 participants
Started: Sep 15, 2025 · Completed: Mar 15, 2029
3 conditions1 sponsor1 location
NCT06994143
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis
PHASE1Recruiting
37 participants
Started: May 19, 2025 · Completed: Dec 30, 2028
1 condition1 sponsor2 locations
NCT06613360
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
PHASE1Recruiting
24 participants
Started: Jan 21, 2025 · Completed: Dec 31, 2027
2 conditions1 sponsor12 locations
NCT06381141
A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma
PHASE1Active, not recruiting
30 participants
Started: Sep 3, 2024 · Completed: Mar 31, 2027
1 condition1 sponsor8 locations
NCT06035744
CLN-617 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
PHASE1Recruiting
86 participants
Started: Dec 12, 2023 · Completed: Jun 30, 2028
1 condition1 sponsor5 locations
NCT05879744
A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)
PHASE1Active, not recruiting
90 participants
Started: May 31, 2023 · Completed: Apr 30, 2027
2 conditions1 sponsor6 locations
NCT05143996
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
PHASE1Recruiting
60 participants
Started: Nov 18, 2021 · Completed: Nov 30, 2025
2 conditions1 sponsor7 locations
NCT05117476
A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
PHASE1Recruiting
440 participants
Started: Oct 29, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor23 locations
NCT04036682
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
PHASE1/PHASE2Active, not recruiting
284 participants
Started: Oct 31, 2019 · Completed: Mar 31, 2026
2 conditions1 sponsor64 locations